MicroCap Investor Disclaimers & Disclosures

1. MicroCap Investor is a weekly newsletter which, along with its related publications and other services (collectively, the "Newsletter"), is edited by Josh Levine, published by Plexus Capital Management, Inc. (for which Josh Levine is president and principal owner), and offered to the general public on a subscription basis. Plexus Capital Management is partnered with InvestorIdeas.com, which provides IT and other operational and marketing services for the Newsletter.

2. Newsletter subscribers will receive the benefit of Josh Levine's commentary, analysis, opinions, advice and recommendations. The Newsletter is impersonal and does not provide individualized advice or recommendations for any specific subscriber or portfolio. Further, the publication by an Editor of a "target price" or "stop loss" for a particular security does not necessarily represent the price at which an Editor intends to sell or will sell any such securities that the Editor may directly or indirectly own.

3. The Editor hereby discloses that on the respective dates set forth below:

The Editor Josh Levine directly or indirectly, owned the following securities which are the subject of the commentary, analysis, opinions, advice, or recommendations in, or which are otherwise mentioned in the newsletter, and those stocks are set forth below:

Date: November 1, 2010

Securities Owned By Josh Levine:

Elephant Talk Communications (ETAK)
Inovio Biomedical (INO)
Oculus Innovative Sciences (OCLS)
Raptor Networks (RPTN)

The Editor has agreed not to buy or sell any of the above-listed securities within a minimum period of 30 trading days before or after making any new recommendation, or changing their published recommendation, regarding these securities in their Newsletter (calculated from the date the Newsletter featuring such recommendation is first posted on levinesmicrocapinvestor.com) unless the market capitalization of the security at the close of business on that date is more than $300 million (the current Standard and Poors' requirement for inclusion in the S&P SmallCap 600 index) in which case, the Editor has agreed to not buy or sell such security within a minimum period of five trading days before or after the applicable date. After the expiration of this period of five or thirty trading days, the Editor may hold, buy or sell such securities, and may cease to own any of the securities listed above. Since the Editor's personal investing goals and risk tolerance may be different from those discussed in the Newsletter and/or circumstances may have changed by the expiration of the five or thirty day restricted period, the investment actions taken by the editor in the accounts the Editor directly or indirectly owns may vary from (and may even be contrary to) the advice and recommendations in the Newsletter. The publication by an Editor of a "target price" or "stop loss" for a particular security does not necessarily represent the price at which an Editor intends to sell or will sell any such securities that the Editor may directly or indirectly own.

4. Investing involves substantial risk. Neither the Editor, the publisher, nor any of their respective affiliates make any guarantee or other promise as to any results that may be obtained from using the Newsletter. While past performance may be analyzed in the Newsletter, past performance should not be considered indicative of future performance. No subscriber should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing the prospectus and other public filings of the issuer. To the maximum extent permitted by law, the Editor, the publisher and their respective affiliates disclaim any and all liability in the event any information, commentary, analysis, opinions, advice and/or recommendations in the Newsletter prove to be inaccurate, incomplete or unreliable, or result in any investment or other losses.

5. The Newsletter's commentary, analysis, opinions, advice and recommendations represent the personal and subjective views of the Editor, and are subject to change at any time without notice.

6. The information provided in the Newsletter is obtained from sources which the Editor believes to be reliable. However, the Editor has not independently verified or otherwise investigated all such information. Neither the Editor, the publisher, nor any of their respective affiliates guarantees the accuracy or completeness of any such information.

7. The Newsletter is not a solicitation or offer to buy or sell any securities.

8. Subscribers may submit questions to the Editor by e-mail to admin@levinesmicrocapinvestor.com. However, since the Newsletter is impersonal and does not provide individualized advice for specific subscribers, the Editor can only answer questions of a general nature about the markets or specific securities. The Editor will make every effort to answer subscriber questions on our website (levinesmicrocapinvestor.com) or in the pages of an upcoming issue of the Newsletter.

9. Neither the Editor, the publisher or any of their respective affiliates is responsible for any errors or omissions in any Newsletter.

10. Any subscriber who would like a copy of these "Disclaimers and Disclosures" may request a copy by calling our partner, InvestorIdeas.com, at 800-665-0411 or by emailing to admin@levinesmicrocapinvestor.com, whereupon a copy will be mailed or faxed to such subscriber.

 

MicroCap Investor Track Record

Over the past two years, MicroCap Investor captured big profits in these stocks:
  
CRIS +410%
ENOC +256%
MXWL +138%
Learn More

ETAK Special Report
The MicroCap Stock of the decade!
Get your FREE copy now
Josh's Top Stock Pick!

What MicroCap Investors have to say…

The 2nd Annual Burrill Digital Health Meeting